pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Marketed
onabotulinumtoxinA
Botox (onabotulinumtoxinA)
Lower Limb Muscle Spasticity
Allergan Sales LLC
Preclinical
onabotulinumtoxinA biosimilar
Blepharospasm
$VTRS
Viatris Inc
Marketed
onasemnogene abeparvovec
Itvisma (onasemnogene abeparvovec-xioi)
Spinal Muscular Atrophy (SMA)
Novartis Gene Therapies
← prev
page 202 of 231
next →
Pain
89
Neurology
1
Phase 3
onfekafusp alfa
onfekafusp alfa [INN]
Soft Tissue Sarcoma
Philogen SpA
Phase 2
onrogadgene parvec
onrogadgene parvec
Parkinson's Disease
$MGTX
MeiraGTx Holdings plc
Phase 2
ontunisertib
ontunisertib
Crohn's Disease (Regional Enteritis)
$AGMB
Agomab Therapeutics NV
Phase 2
onvansertib fumarate
onvansertib fumarate
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$CRDF
Cardiff Oncology, Inc.
Phase 2
onvapegleukin alfa
onvapegleukin alfa
Cervical Cancer
Ascendis Pharma AS
Phase 3
onvuzosiran sodium
onvuzosiran sodium
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-IN…
ADARx Pharmaceuticals Inc
Phase 2
onzemipgene parvec
onzemipgene parvec [INN]
Dry (Atrophic) Macular Degeneration
$JNJ
JOHNSON & JOHNSON
Phase 2
opaganib
YELIVA (opaganib [INN])
Bile Duct Cancer (Cholangiocarcinoma)
$RDHL
RedHill Biopharma Ltd.
Phase 3
opiranserin
opiranserin [INN]
Post-Operative Pain
Vivozon Inc
Phase 2
ordastobart
ordastobart
Adenocarcinoma Of The Gastroesophageal Junction
$INBX
Inhibrx Biosciences, Inc.
Phase 3
oregovomab
Ovarex (oregovomab)
Fallopian Tube Cancer
OncoQuest Inc
Phase 3
orelabrutinib
orelabrutinib
Primary Progressive Multiple Sclerosis (PPMS)
$ZBIO
Zenas BioPharma, Inc.
Phase 2
orismilast
orismilast [INN]
Plaque Psoriasis (Psoriasis Vulgaris)
Union Therapeutics AS
Marketed
oritavancin diphosphate
Orbactiv (oritavancin diphosphate)
Skin And Skin Structure Infections (SSSI) Caused By Bacteria
A. Menarini Industrie Farmaceutiche Riunite Srl
Marketed
orlistat
Xenical (orlistat)
Obesity
H2-Pharma LLC
Marketed
orphenadrine citrate ER
Orphenadrine Citrate
Musculoskeletal Pain
Lupin Research Inc
Phase 2
orvacabtagene autoleucel
orvacabtagene autoleucel
Refractory Multiple Myeloma
Bristol-Myers Squibb Co
Phase 2
orvepitant
orvepitant
Chronic Cough
NeRRe Therapeutics Ltd
Phase 2
orziloben
orziloben
Liver Diseases
NorthSea Therapeutics BV
Phase 2
osemitamab
osemitamab
Gastroesophageal (GE) Junction Carcinomas
Transcenta Holding Ltd
Marketed
osimertinib mesylate
Tagrisso (osimertinib mesylate)
Non-Small Cell Lung Cancer
$AZN
ASTRAZENECA PLC
Phase 3
osivelotor
osivelotor
Sickle Cell Disease
$PFE
PFIZER INC
Marketed
ospemifene
Osphena (ospemifene)
Atrophic Vaginitis (Vaginal Atrophy/Vulvovaginal Atrophy/…
Duchesnay USA Inc
Marketed
oteseconazole
Vivjoa (oteseconazole)
Onychomycosis (Tinea Unguium)
Mycovia Pharmaceuticals Inc
pre_registration
oveporexton
oveporexton
Type 1 Narcolepsy (Narcolepsy with Cataplexy)
$TAK
TAKEDA PHARMACEUTICAL CO LTD
Marketed
oxacillin
Bactocill (oxacillin [INN])
Staphylococcal Infections
Baxter Healthcare Corp
Marketed
oxacillin sodium
Oxacillin Sodium
Abscess
Eugia US LLC
